Correlation Between Petros Pharmaceuticals and Alimera Sciences

Can any of the company-specific risk be diversified away by investing in both Petros Pharmaceuticals and Alimera Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Petros Pharmaceuticals and Alimera Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Petros Pharmaceuticals and Alimera Sciences, you can compare the effects of market volatilities on Petros Pharmaceuticals and Alimera Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Petros Pharmaceuticals with a short position of Alimera Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Petros Pharmaceuticals and Alimera Sciences.

Diversification Opportunities for Petros Pharmaceuticals and Alimera Sciences

-0.2

Correlation Coefficient

Petros Pharmaceuticals  Alimera Sciences

Good diversification

The 3 months correlation between Petros and Alimera is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Petros Pharmaceuticals and Alimera Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alimera Sciences and Petros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Petros Pharmaceuticals are associated (or correlated) with Alimera Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alimera Sciences has no effect on the direction of Petros Pharmaceuticals i.e., Petros Pharmaceuticals and Alimera Sciences go up and down completely randomly.

Pair Corralation between Petros Pharmaceuticals and Alimera Sciences

If you would invest  27.00  in Petros Pharmaceuticals on October 1, 2024 and sell it today you would earn a total of  9.40  from holding Petros Pharmaceuticals or generate 34.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	4.76%
Values	Daily Returns

Petros Pharmaceuticals  vs.  Alimera Sciences

Petros Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Petros Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Petros Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Alimera Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alimera Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Alimera Sciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Petros Pharmaceuticals and Alimera Sciences

The main advantage of trading using opposite Petros Pharmaceuticals and Alimera Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Petros Pharmaceuticals position performs unexpectedly, Alimera Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alimera Sciences will offset losses from the drop in Alimera Sciences' long position.

The idea behind Petros Pharmaceuticals and Alimera Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.